“Evaluation of Response to Ritlecitinib Treatment Based on SALT Improvement Scores in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study”, J of Skin, vol. 7, no. 2, p. s187, Mar. 2023, doi: 10.25251/skin.7.supp.187.